Pharma & Healthcare

Global Influenza Treatment Market Research Report 2025

The global market for Influenza Treatment was valued at US$ 6161 million in the year 2024 and is projected to reach a revised size of US$ 7305 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Flu, also called influenza, is an infection of the nose, throat and lungs, which are part of the respiratory system. The flu is caused by a virus.
The growth of the market is attributed to factors such as emerging seasonal flu, increased prevalence of contagious respiratory illness, and growing patient populations at greater risk for seasonal flu-related complications drives the market growth. 
This report aims to provide a comprehensive presentation of the global market for Influenza Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Treatment.
The Influenza Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Treatment market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
Market Segmentation
By Company
Novartis AG
Roche Holding
BioCryst Pharmaceuticals
Sanofi
GSK plc.
Viatris Inc. (Mylan)
Teva Pharmaceutical Industries Ltd.
Daiichi Sankyo
AstraZeneca
NATCO Pharma Limited
Gilead Sciences
Segment by Type
Peramivir
Zanamivir
Baloxavir Marboxil
Oseltamivir Phosphate
Others
Segment by Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Peramivir
1.2.3 Zanamivir
1.2.4 Baloxavir Marboxil
1.2.5 Oseltamivir Phosphate
1.2.6 Others
1.3 Market by Channel
1.3.1 Global Influenza Treatment Market Growth by Channel: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Treatment Market Perspective (2020-2031)
2.2 Global Influenza Treatment Growth Trends by Region
2.2.1 Global Influenza Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Influenza Treatment Historic Market Size by Region (2020-2025)
2.2.3 Influenza Treatment Forecasted Market Size by Region (2026-2031)
2.3 Influenza Treatment Market Dynamics
2.3.1 Influenza Treatment Industry Trends
2.3.2 Influenza Treatment Market Drivers
2.3.3 Influenza Treatment Market Challenges
2.3.4 Influenza Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Treatment Players by Revenue
3.1.1 Global Top Influenza Treatment Players by Revenue (2020-2025)
3.1.2 Global Influenza Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Influenza Treatment Revenue
3.4 Global Influenza Treatment Market Concentration Ratio
3.4.1 Global Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Treatment Revenue in 2024
3.5 Global Key Players of Influenza Treatment Head office and Area Served
3.6 Global Key Players of Influenza Treatment, Product and Application
3.7 Global Key Players of Influenza Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Treatment Breakdown Data by Type
4.1 Global Influenza Treatment Historic Market Size by Type (2020-2025)
4.2 Global Influenza Treatment Forecasted Market Size by Type (2026-2031)
5 Influenza Treatment Breakdown Data by Channel
5.1 Global Influenza Treatment Historic Market Size by Channel (2020-2025)
5.2 Global Influenza Treatment Forecasted Market Size by Channel (2026-2031)
6 North America
6.1 North America Influenza Treatment Market Size (2020-2031)
6.2 North America Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Influenza Treatment Market Size by Country (2020-2025)
6.4 North America Influenza Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Treatment Market Size (2020-2031)
7.2 Europe Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Influenza Treatment Market Size by Country (2020-2025)
7.4 Europe Influenza Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Treatment Market Size (2020-2031)
8.2 Asia-Pacific Influenza Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Influenza Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Influenza Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Treatment Market Size (2020-2031)
9.2 Latin America Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Influenza Treatment Market Size by Country (2020-2025)
9.4 Latin America Influenza Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Treatment Market Size (2020-2031)
10.2 Middle East & Africa Influenza Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Influenza Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Influenza Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Influenza Treatment Introduction
11.1.4 Novartis AG Revenue in Influenza Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Details
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Influenza Treatment Introduction
11.2.4 Roche Holding Revenue in Influenza Treatment Business (2020-2025)
11.2.5 Roche Holding Recent Development
11.3 BioCryst Pharmaceuticals
11.3.1 BioCryst Pharmaceuticals Company Details
11.3.2 BioCryst Pharmaceuticals Business Overview
11.3.3 BioCryst Pharmaceuticals Influenza Treatment Introduction
11.3.4 BioCryst Pharmaceuticals Revenue in Influenza Treatment Business (2020-2025)
11.3.5 BioCryst Pharmaceuticals Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Influenza Treatment Introduction
11.4.4 Sanofi Revenue in Influenza Treatment Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 GSK plc.
11.5.1 GSK plc. Company Details
11.5.2 GSK plc. Business Overview
11.5.3 GSK plc. Influenza Treatment Introduction
11.5.4 GSK plc. Revenue in Influenza Treatment Business (2020-2025)
11.5.5 GSK plc. Recent Development
11.6 Viatris Inc. (Mylan)
11.6.1 Viatris Inc. (Mylan) Company Details
11.6.2 Viatris Inc. (Mylan) Business Overview
11.6.3 Viatris Inc. (Mylan) Influenza Treatment Introduction
11.6.4 Viatris Inc. (Mylan) Revenue in Influenza Treatment Business (2020-2025)
11.6.5 Viatris Inc. (Mylan) Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Influenza Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Influenza Treatment Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Influenza Treatment Introduction
11.8.4 Daiichi Sankyo Revenue in Influenza Treatment Business (2020-2025)
11.8.5 Daiichi Sankyo Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Influenza Treatment Introduction
11.9.4 AstraZeneca Revenue in Influenza Treatment Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 NATCO Pharma Limited
11.10.1 NATCO Pharma Limited Company Details
11.10.2 NATCO Pharma Limited Business Overview
11.10.3 NATCO Pharma Limited Influenza Treatment Introduction
11.10.4 NATCO Pharma Limited Revenue in Influenza Treatment Business (2020-2025)
11.10.5 NATCO Pharma Limited Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Influenza Treatment Introduction
11.11.4 Gilead Sciences Revenue in Influenza Treatment Business (2020-2025)
11.11.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Peramivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Baloxavir Marboxil
Table 5. Key Players of Oseltamivir Phosphate
Table 6. Key Players of Others
Table 7. Global Influenza Treatment Market Size Growth by Channel (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Influenza Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Influenza Treatment Market Share by Region (2020-2025)
Table 11. Global Influenza Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Influenza Treatment Market Share by Region (2026-2031)
Table 13. Influenza Treatment Market Trends
Table 14. Influenza Treatment Market Drivers
Table 15. Influenza Treatment Market Challenges
Table 16. Influenza Treatment Market Restraints
Table 17. Global Influenza Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Influenza Treatment Market Share by Players (2020-2025)
Table 19. Global Top Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Treatment as of 2024)
Table 20. Ranking of Global Top Influenza Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Influenza Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Influenza Treatment, Headquarters and Area Served
Table 23. Global Key Players of Influenza Treatment, Product and Application
Table 24. Global Key Players of Influenza Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Influenza Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Influenza Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Influenza Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Influenza Treatment Market Size by Channel (2020-2025) & (US$ Million)
Table 31. Global Influenza Treatment Revenue Market Share by Channel (2020-2025)
Table 32. Global Influenza Treatment Forecasted Market Size by Channel (2026-2031) & (US$ Million)
Table 33. Global Influenza Treatment Revenue Market Share by Channel (2026-2031)
Table 34. North America Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Influenza Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Influenza Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Influenza Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Influenza Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Novartis AG Company Details
Table 50. Novartis AG Business Overview
Table 51. Novartis AG Influenza Treatment Product
Table 52. Novartis AG Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 53. Novartis AG Recent Development
Table 54. Roche Holding Company Details
Table 55. Roche Holding Business Overview
Table 56. Roche Holding Influenza Treatment Product
Table 57. Roche Holding Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 58. Roche Holding Recent Development
Table 59. BioCryst Pharmaceuticals Company Details
Table 60. BioCryst Pharmaceuticals Business Overview
Table 61. BioCryst Pharmaceuticals Influenza Treatment Product
Table 62. BioCryst Pharmaceuticals Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 63. BioCryst Pharmaceuticals Recent Development
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Influenza Treatment Product
Table 67. Sanofi Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. GSK plc. Company Details
Table 70. GSK plc. Business Overview
Table 71. GSK plc. Influenza Treatment Product
Table 72. GSK plc. Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 73. GSK plc. Recent Development
Table 74. Viatris Inc. (Mylan) Company Details
Table 75. Viatris Inc. (Mylan) Business Overview
Table 76. Viatris Inc. (Mylan) Influenza Treatment Product
Table 77. Viatris Inc. (Mylan) Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 78. Viatris Inc. (Mylan) Recent Development
Table 79. Teva Pharmaceutical Industries Ltd. Company Details
Table 80. Teva Pharmaceutical Industries Ltd. Business Overview
Table 81. Teva Pharmaceutical Industries Ltd. Influenza Treatment Product
Table 82. Teva Pharmaceutical Industries Ltd. Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd. Recent Development
Table 84. Daiichi Sankyo Company Details
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Influenza Treatment Product
Table 87. Daiichi Sankyo Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 88. Daiichi Sankyo Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Influenza Treatment Product
Table 92. AstraZeneca Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. NATCO Pharma Limited Company Details
Table 95. NATCO Pharma Limited Business Overview
Table 96. NATCO Pharma Limited Influenza Treatment Product
Table 97. NATCO Pharma Limited Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 98. NATCO Pharma Limited Recent Development
Table 99. Gilead Sciences Company Details
Table 100. Gilead Sciences Business Overview
Table 101. Gilead Sciences Influenza Treatment Product
Table 102. Gilead Sciences Revenue in Influenza Treatment Business (2020-2025) & (US$ Million)
Table 103. Gilead Sciences Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report


List of Figures
Figure 1. Influenza Treatment Picture
Figure 2. Global Influenza Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Influenza Treatment Market Share by Type: 2024 VS 2031
Figure 4. Peramivir Features
Figure 5. Zanamivir Features
Figure 6. Baloxavir Marboxil Features
Figure 7. Oseltamivir Phosphate Features
Figure 8. Others Features
Figure 9. Global Influenza Treatment Market Size by Channel (2020-2031) & (US$ Million)
Figure 10. Global Influenza Treatment Market Share by Channel: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Influenza Treatment Report Years Considered
Figure 15. Global Influenza Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Influenza Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Influenza Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Influenza Treatment Market Share by Players in 2024
Figure 19. Global Top Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Influenza Treatment Revenue in 2024
Figure 21. North America Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Influenza Treatment Market Share by Country (2020-2031)
Figure 23. United States Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Influenza Treatment Market Share by Country (2020-2031)
Figure 27. Germany Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Influenza Treatment Market Share by Region (2020-2031)
Figure 35. China Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Influenza Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Influenza Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Influenza Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Novartis AG Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 51. Roche Holding Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 52. BioCryst Pharmaceuticals Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 54. GSK plc. Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 55. Viatris Inc. (Mylan) Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 57. Daiichi Sankyo Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 59. NATCO Pharma Limited Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 60. Gilead Sciences Revenue Growth Rate in Influenza Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies